QR Code

The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies

Abstract Background As the technology of next generation sequencing rapidly develops and costs are constantly reduced, the clinical availability of whole genome sequencing (WGS) increases. Thereby, it remains unclear what exact advantage WGS offers in comparison to whole exome sequencing (WES) for t...

Full description

Saved in:
Main Authors: Anna Grether, Ivan Ivanovski, Martina Russo, Anaïs Begemann, Katharina Steindl, Lucia Abela, Michael Papik, Markus Zweier, Beatrice Oneda, Pascal Joset, Anita Rauch
Format: Artigo
Language:Inglês
Published: Wiley 2023-05-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
diagnostic yield
epileptic encephalopathy
whole exome sequencing
whole genome sequencing
Online Access:https://doi.org/10.1002/mgg3.2148
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items